背景:关于慢性咳嗽的教育计划可以改善病人的护理,但对加拿大医生如何管理这种常见的衰弱状况知之甚少。我们的目的是调查加拿大医生的看法,态度,和慢性咳嗽的知识。
方法:我们进行了10分钟的匿名,在线,对Leger意见小组中的3321名加拿大医生进行横断面调查,这些医生管理患有慢性咳嗽的成年患者,并已执业超过2年.
结果:在2021年7月30日至9月22日期间,共有179名医生(101名全科医生和78名专家[25名过敏症专家,28名呼吸科医生,和25名耳/鼻/喉专家])完成了调查(回应率:5.4%)。一个月后,全科医生平均看到27例慢性咳嗽患者,而专家看到了46。大约三分之一的医生适当地将>8周的持续时间确定为慢性咳嗽的定义。许多医生报告没有使用国际慢性咳嗽管理指南。患者转诊和护理途径差异很大,患者经常经历失访。虽然医生认可鼻和吸入糖皮质激素作为慢性咳嗽的常用治疗方法,他们很少使用其他指南推荐的治疗方法.全科医生和专家都对慢性咳嗽的教育表示了浓厚的兴趣。
结论:这项对加拿大医生的调查表明,对慢性咳嗽诊断的最新进展的了解较低,疾病分类,和药物管理。加拿大医生还报告说,对指南推荐的疗法不熟悉,包括治疗难治性或无法解释的慢性咳嗽的中枢作用神经调质。这些数据强调了在初级和专科护理中对慢性咳嗽的教育计划和协作护理模式的需求。
Educational programs on chronic cough may improve patient care, but little is known about how Canadian physicians manage this common debilitating condition. We aimed to investigate Canadian physicians\' perceptions, attitudes, and knowledge of chronic cough.
We administered a 10-min anonymous, online, cross-sectional survey to 3321 Canadian physicians in the Leger Opinion Panel who managed adult patients with chronic cough and had been in practice for > 2 years.
Between July 30 and September 22, 2021, 179 physicians (101 general practitioners [GPs] and 78 specialists [25 allergists, 28 respirologists, and 25 ear/nose/throat specialists]) completed the survey (response rate: 5.4%). In a month, GPs saw a mean of 27 patients with chronic cough, whereas specialists saw 46. About one-third of physicians appropriately identified a duration of > 8 weeks as the definition for chronic cough. Many physicians reported not using international chronic cough management
guidelines. Patient referrals and care pathways varied considerably, and patients frequently experienced lost to follow-up. While physicians endorsed nasal and inhaled corticosteroids as common treatments for chronic cough, they rarely used other
guideline-recommended treatments. Both GPs and specialists expressed high interest in education on chronic cough.
This survey of Canadian physicians demonstrates low uptake of recent advances in chronic cough diagnosis, disease categorization, and pharmacologic management. Canadian physicians also report unfamiliarity with
guideline-recommended therapies, including centrally acting neuromodulators for refractory or unexplained chronic cough. This data highlights the need for educational programs and collaborative care models on chronic cough in primary and specialist care.